Indoco Remedies (NSE: INDOCO) is a leading Indian pharmaceutical company that operates in both domestic and international markets. The company has a diverse product portfolio that includes prescription drugs, over-the-counter (OTC) medicines, and veterinary products. Indoco Remedies has a strong presence in India and operates in more than 80 countries worldwide.
Quarterly Earnings Summary:
- Indoco Remedies reported a consolidated revenue of ₹411.15 crore for Q3 FY 2023, an increase of 18% compared to the same quarter of the previous year.
- The company’s net profit for Q3 FY 2023 stood at ₹28.14 crore, a decline from Net Profit of ₹33 crore in the same quarter of the previous year.
- The company’s domestic business recorded a growth of 11%, while the international business grew by 26% during the quarter.
- The Earnings Per Share was ₹3.05 for this quarter.
Most Popular
Cochin Shipyard Ltd (COCHINSHIP) Q4 FY22 Earnings Concall Transcript
Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah
All you need to know about Antony Waste Handling Cell in one article
Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?
Demystifying the Leading Non-Ferrous Recycling Company of India
“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,